Rubin Patel, MD
Internal Medicine · Orangeburg, SCNPI 1336587526
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 30.3% of the total. Reporting peaked in 2019 at $353 and has fallen 68.6% since, to $111 in 2025.
Across 98 payments — averaging $16.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$500
- Novartis$413
- E.r. Squibb & Sons, L.L.C.$295
- AbbVie$108
- Merck$94
- AstraZeneca$89
- plus $147 from 4 others
Across 25 payments — averaging $7254.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Roche Molecular Systems, Inc.$181K
What the payments were for
- Food & beverage$1,646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 35 | $500 |
| Novartis | 23 | $413 |
| E.r. Squibb & Sons, L.L.C. | 16 | $295 |
| AbbVie(2 entities) | 6 | $108 |
| Merck | 6 | $94 |
| AstraZeneca | 5 | $89 |
| Cvrx, Inc. | 2 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $40 |
| Medtronic(2 entities) | 2 | $28 |
| Lexicon Pharmaceuticals, Inc. | 1 | $23 |
How this compares
$1,646 in reported general payments places this provider in the 75th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $11,952 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 30 | $150 |
| Pantoprazole Sodium | 28 | $126 |
| Gabapentin | 12 | $90 |
| Oxycodone Hcl | 17 | $64 |
| Donepezil Hcl | 30 | $62 |
| Levofloxacin | 11 | $61 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $51 |
| Prednisone | 11 | $44 |
| Carvedilol | 13 | $33 |
| Amlodipine Besylate | 15 | $25 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Orangeburg
- Jerry BackNorth Charleston$322K
- Jan BasileCharleston$278K
- Mark PurcellGreenville$165K
- John CleekCharleston$136K
- William BunnHilton Head Island$125K
- Zion LammGreenville$118K
- Bruce GrayGreenville$111K
- Leonard AlsfeldCharleston$91K
- Edward Botse-BaidooMyrtle Beach$90K
- Lisa DarbyGreenville$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.